Therapy-Related Leukemia — Trials

Therapy-Related Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

59 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 18
Recruiting: 7
Ph III recruiting: 0
Growth YoY: —
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 18.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03407859	Sequential Treatment With CD20/CD22/CD10-CART After CD19-CART Treatment Base on MRD in Relapsed/Refractory B-ALL	unknown	Early Phase 1	100	Zhujiang HospitalOTHER	1	Mar 15, 2024	clinicaltrials
NCT01619761	NK Cells in Cord Blood Transplantation	unknown	Phase 1	13	M.D. Anderson Cancer CenterOTHER	1	Feb 11, 2020	clinicaltrials